About Medical Foam
Over the past few decades’ experience of supplying a wide range of medical foams Developing, processing and manufacturing foams for medical applications is a specialized field with many factors to consider – including performance, biocompatibility, sterilization, and the potential for skin irritation. The medical foam was developed in healthcare to ease aches and pains, and others to return to better health whilst being incredibly comfortable. It is specifically designed to relieve pressure and help maintain and improve the quality of life and many more benefits. With increasing health care expenditure in developing countries, the demand for medical foam is increasing across the globe.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Medical Foam market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Dow Chemical Company (United States), SEKISUI CHEMICAL CO., LTD. (Japan), Huntsman Corporation (United States), Trelleborg AB (Sweden), UFP Technologies, Inc. (United States), BASF SE (Germany), Recticel NV (Belgium), INOAC Corporation (Japan), FXI Holdings, Inc. (United States) and Rogers Corporation (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Freudenberg Group (Germany), FoamPartner Group (Switzerland), General Plastics Manufacturing Company (United States), Armacell International S.A. (Germany), Mölnlycke Health Care AB (Sweden) and VPC Group Inc. (Canada).
Segmentation Overview
AMA Research has segmented the market of Global Medical Foam market by Type (Polyurethane, Polystyrene and Polyolefin), Application (Medical Packaging, Medical Devices & Components and Prosthetics & Wound Care) and Region.
On the basis of geography, the market of Medical Foam has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the Medical Foam market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by By Form, the sub-segment i.e. Flexible Foam will boost the Medical Foam market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
High demand for high-quality medical-grade foam that is suitable for multiple applications
Market Growth Drivers:
An increase in the aging population & the need for patient comfort is expected to drive the bedding & cushioning, The rise in demand for sustainable packaging solutions in healthcare and The emergence of new foam materials
Challenges:
Fluctuations in raw material prices
Restraints:
Stringent rules & regulations
Opportunities:
The rise in global healthcare expenditure
Market Leaders and their expansionary development strategies
In May, 2023 Probo Medical a leading global provider of medical imaging equipment, parts, repair and service, announced today that it has completed its acquisition of the MRI coil repair operation from Creative Foam, Inc., a Fenton, Michigan based solutions provider specializing in the design, engineering, and manufacturing of a range of solutions in the transportation and healthcare markets.
In September 2019 Merit Medical introduced its new form of medical foam named Torpedo Gelatin Foam for Embolization of Hypervascular Tumors. It offers benefits to the general practitioner with a preshaped gelatin foam loaded into a cartridge with an optional blunt stylet, removing the need for manual foam shaping and providing fast and easy attachment to the catheter for delivery.
“510 K clearance by the FDA A 510(k) is a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device (section 513(i)(1)(A) FD&C Act). This is where foam formulations are registered with the FDA. It is important to remember that foam with an FDA master &64257;le means that the formulation is registered with the FDA. It does not necessarily mean that the foam is “medical grade.” Additional biocompatibility testing will determine whether or not the foam is appropriate for use in medical applications.”
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Medical Foam Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.